This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Anything new in the control of myopia progression?

Anything new in the control of myopia progression?
Reviewed by Zhihang Cheng

1 October 2021 | Zhihang Cheng | EYE - Vitreo-Retinal | Axial length, Children, Efficacy, Myopia, Myopia control, Retinal disease
Share This

This is a review article looking at up to date concepts and evidence in myopia control from current literature and studies. The authors identified that myopia control is best measured in absolute change in axial length as opposed to refraction error. The authors encourage the use of Cumulative, Absolute and Reduction in axial Elongation (CARE) in measuring myopia outcomes. They sound caution that myopia control treatment efficacy is not as good as previously thought. Finally, past progression is not a good indicator of future progression and the authors feel all myopic children aged 12 and under should be treated and treated aggressively.

Efficacy in myopia control.
Brennan NA, Toubouti YM, Cheng X, Bullimore MA.
PROGRESS IN RETINAL AND EYE RESEARCH
2021;83:100923.
Share This
CONTRIBUTOR
Zhihang Cheng

Alder Hey Children’s Hospital, Liverpool, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency